Document is current
Any future updates will be listed below
-
Authors
Lumlertgul, Nuttha
Baker, Eleanor
Pearson, Emma
Dalrymple, Kathryn V.
Pan, Jacqueline
Jheeta, Anup
Weerapolchai, Kittisak
Wang, Yanzhong
Leach, Richard
Barrett, Nicholas A.
Ostermann, Marlies http://orcid.org/0000-0001-9500-9080
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04445259 at ClinicalTrials.govDocuments that mention this clinical trial
Changing epidemiology of acute kidney injury in critically ill patients with COVID-19: a prospective cohort
https://doi.org/10.1186/s13613-022-01094-6
-
Funding
Funding for this research was provided by:
Baxter International
bioMérieux
- License Information
-
More Information
Article History
Received: 13 July 2022
Accepted: 8 December 2022
First Online: 28 December 2022
Declarations
:
: Ethical approval was obtained from the Health Research Authority and the Research Ethics Committee Health and Care Research Wales (REC Reference 20/WA/0175). Informed consent was obtained from the patients, personal, or professional consultee.
: Not applicable.
: MO received speaker honoraria from Baxter, Fresenius Medical and Biomerieux and research funding from Baxter, Fresenius, Biomerieux and LaJolla Pharma. All other authors declare no competing interests.
